Jessica R Abramson1, Juan Pablo Castello1, Sophia Keins1, Christina Kourkoulis1, Axana Rodriguez-Torres1, Evangelos Pavlos Myserlis1, Haitham Alabsi1, Andrew D Warren1, Jonathan Q A Henry1, M Edip Gurol1, Anand Viswanathan1, Steven M Greenberg1, Amytis Towfighi1, Lesli Skolarus1, Christopher D Anderson1, Jonathan Rosand1, Alessandro Biffi2. 1. From the Henry and Allison McCance Center for Brain Health (J.R.A., J.P.C., S.K., C.K., E.P.M., H.A., J.Q.A.H., C.D.A., J.R., A.B.), Department of Neurology (J.R.A., J.P.C., S.K., C.K., E.P.M., H.A., A.D.W., J.Q.A.H., M.E.G., A.V., S.M.G., C.D.A., J.R., A.B.), and Center for Genomic Medicine (J.R.A., S.K., C.K., E.P.M., J.Q.A.H., C.D.A., J.R., A.B.), Massachusetts General Hospital, Boston; School of Medicine (A.R.-T.), University of California, Irvine; Department of Neurology (A.T.), Keck School of Medicine, University of Southern California, Los Angeles; Los Angeles County Department of Health Services (A.T.), CA; Stroke Program (L.S.), University of Michigan Medical School, Ann Arbor; and Department of Neurology (C.D.A.), Brigham and Women's Hospital, Boston, MA. 2. From the Henry and Allison McCance Center for Brain Health (J.R.A., J.P.C., S.K., C.K., E.P.M., H.A., J.Q.A.H., C.D.A., J.R., A.B.), Department of Neurology (J.R.A., J.P.C., S.K., C.K., E.P.M., H.A., A.D.W., J.Q.A.H., M.E.G., A.V., S.M.G., C.D.A., J.R., A.B.), and Center for Genomic Medicine (J.R.A., S.K., C.K., E.P.M., J.Q.A.H., C.D.A., J.R., A.B.), Massachusetts General Hospital, Boston; School of Medicine (A.R.-T.), University of California, Irvine; Department of Neurology (A.T.), Keck School of Medicine, University of Southern California, Los Angeles; Los Angeles County Department of Health Services (A.T.), CA; Stroke Program (L.S.), University of Michigan Medical School, Ann Arbor; and Department of Neurology (C.D.A.), Brigham and Women's Hospital, Boston, MA. abiffi@mgh.harvard.edu.
Abstract
BACKGROUND AND OBJECTIVES: Although blood pressure (BP) control is considered the most effective measure to prevent functional decline after intracerebral hemorrhage (ICH), fewer than half of survivors achieve treatment goals. We hypothesized that long-term (i.e., prehemorrhage) hypertension severity may be a crucial factor in explaining poor BP control after ICH. We investigated changes in hypertension severity after vs before ICH using latent class analysis (LCA) and identified patient characteristics predictive of individuals' BP trajectories. METHODS: We analyzed data for ICH survivors enrolled in a study conducted at Massachusetts General Hospital (MGH) from 2002 to 2019 in Boston, a high-resource setting with near-universal medical insurance coverage. We captured BP measurements in the 12 months preceding and following the acute ICH hospitalization. Using LCA, we identified patient groups (classes) based on changes in hypertension severity over time in an unbiased manner. We then created multinomial logistic regression models to identify patient factors associated with these classes. RESULTS: Among 336 participants, the average age was 74.4 years, 166 (49%) were male, and 288 (86%) self-reported White race/ethnicity. LCA identified 3 patient classes, corresponding to minimal (n = 114, 34%), intermediate (n = 128, 38%), and substantial (n = 94, 28%) improvement in hypertension severity after vs before ICH. Survivors with undertreated (relative risk ratio [RRR] 0.05, 95% CI 0.01-0.23) or resistant (RRR 0.03, 95% CI 0.01-0.06) hypertension before ICH were less likely to experience substantial improvement afterwards. Residents of high-income neighborhoods were more likely to experience substantial improvement (RRR 1.14 per $10,000, 95% CI 1.02-1.28). Black, Hispanic, and Asian participants with uncontrolled hypertension before ICH were more likely to experience minimal improvement after hemorrhagic stroke (interaction p < 0.001). DISCUSSION: Most ICH survivors do not display consistent improvement in hypertension severity after hemorrhagic stroke. BP control after ICH is profoundly influenced by patient characteristics predating the hemorrhage, chiefly prestroke hypertension severity and socioeconomic status. Neighborhood income was associated with hypertension severity after ICH in a high-resource setting with near-universal health care coverage. These findings likely contribute to previously documented racial/ethnic disparities in BP control and clinical outcomes following ICH.
BACKGROUND AND OBJECTIVES: Although blood pressure (BP) control is considered the most effective measure to prevent functional decline after intracerebral hemorrhage (ICH), fewer than half of survivors achieve treatment goals. We hypothesized that long-term (i.e., prehemorrhage) hypertension severity may be a crucial factor in explaining poor BP control after ICH. We investigated changes in hypertension severity after vs before ICH using latent class analysis (LCA) and identified patient characteristics predictive of individuals' BP trajectories. METHODS: We analyzed data for ICH survivors enrolled in a study conducted at Massachusetts General Hospital (MGH) from 2002 to 2019 in Boston, a high-resource setting with near-universal medical insurance coverage. We captured BP measurements in the 12 months preceding and following the acute ICH hospitalization. Using LCA, we identified patient groups (classes) based on changes in hypertension severity over time in an unbiased manner. We then created multinomial logistic regression models to identify patient factors associated with these classes. RESULTS: Among 336 participants, the average age was 74.4 years, 166 (49%) were male, and 288 (86%) self-reported White race/ethnicity. LCA identified 3 patient classes, corresponding to minimal (n = 114, 34%), intermediate (n = 128, 38%), and substantial (n = 94, 28%) improvement in hypertension severity after vs before ICH. Survivors with undertreated (relative risk ratio [RRR] 0.05, 95% CI 0.01-0.23) or resistant (RRR 0.03, 95% CI 0.01-0.06) hypertension before ICH were less likely to experience substantial improvement afterwards. Residents of high-income neighborhoods were more likely to experience substantial improvement (RRR 1.14 per $10,000, 95% CI 1.02-1.28). Black, Hispanic, and Asian participants with uncontrolled hypertension before ICH were more likely to experience minimal improvement after hemorrhagic stroke (interaction p < 0.001). DISCUSSION: Most ICH survivors do not display consistent improvement in hypertension severity after hemorrhagic stroke. BP control after ICH is profoundly influenced by patient characteristics predating the hemorrhage, chiefly prestroke hypertension severity and socioeconomic status. Neighborhood income was associated with hypertension severity after ICH in a high-resource setting with near-universal health care coverage. These findings likely contribute to previously documented racial/ethnic disparities in BP control and clinical outcomes following ICH.
Authors: Alina S Schnake-Mahl; Jaquelyn L Jahn; S V Subramanian; Mary C Waters; Mariana Arcaya Journal: J Urban Health Date: 2020-02 Impact factor: 3.671
Authors: Darin B Zahuranec; Jeffrey J Wing; Dorothy F Edwards; Ravi S Menon; Stephen J Fernandez; Richard E Burgess; Ian A Sobotka; Laura German; Anna J Trouth; Nawar M Shara; M Chris Gibbons; Bernadette Boden-Albala; Chelsea S Kidwell Journal: Stroke Date: 2012-08-16 Impact factor: 7.914
Authors: Alessandro Biffi; Destiny Bailey; Christopher D Anderson; Alison M Ayres; Edip M Gurol; Steven M Greenberg; Jonathan Rosand; Anand Viswanathan Journal: JAMA Neurol Date: 2016-08-01 Impact factor: 18.302
Authors: Daniel Woo; Mary Haverbusch; Padmini Sekar; Brett Kissela; Jane Khoury; Alexander Schneider; Dawn Kleindorfer; Jerzy Szaflarski; Arthur Pancioli; Edward Jauch; Charles Moomaw; Laura Sauerbeck; James Gebel; Joseph Broderick Journal: Stroke Date: 2004-05-20 Impact factor: 7.914
Authors: Steven M Greenberg; Brian J Bacskai; Mar Hernandez-Guillamon; Jeremy Pruzin; Reisa Sperling; Susanne J van Veluw Journal: Nat Rev Neurol Date: 2019-12-11 Impact factor: 42.937
Authors: Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright Journal: Hypertension Date: 2017-11-13 Impact factor: 9.897
Authors: Lauren A Taylor; Annabel Xulin Tan; Caitlin E Coyle; Chima Ndumele; Erika Rogan; Maureen Canavan; Leslie A Curry; Elizabeth H Bradley Journal: PLoS One Date: 2016-08-17 Impact factor: 3.240
Authors: Sandro Marini; Katherine Crawford; Andrea Morotti; Myung J Lee; Alessandro Pezzini; Charles J Moomaw; Matthew L Flaherty; Joan Montaner; Jaume Roquer; Jordi Jimenez-Conde; Eva Giralt-Steinhauer; Roberto Elosua; Elisa Cuadrado-Godia; Carolina Soriano-Tarraga; Agnieszka Slowik; Jeremiasz M Jagiella; Joanna Pera; Andrzej Urbanik; Alexander Pichler; Björn M Hansen; Jacob L McCauley; David L Tirschwell; Magdy Selim; Devin L Brown; Scott L Silliman; Bradford B Worrall; James F Meschia; Chelsea S Kidwell; Fernando D Testai; Steven J Kittner; Helena Schmidt; Christian Enzinger; Ian J Deary; Kristiina Rannikmae; Neshika Samarasekera; Rustam Al-Shahi Salman; Catherine L Sudlow; Catharina J M Klijn; Koen M van Nieuwenhuizen; Israel Fernandez-Cadenas; Pilar Delgado; Bo Norrving; Arne Lindgren; Joshua N Goldstein; Anand Viswanathan; Steven M Greenberg; Guido J Falcone; Alessandro Biffi; Carl D Langefeld; Daniel Woo; Jonathan Rosand; Christopher D Anderson Journal: JAMA Neurol Date: 2019-04-01 Impact factor: 18.302